How can we help?
$60.00
Gain knowledge about the plant origin of CBD and THC and an understanding of the metabolism profile for CBD in urine. This session will examine the effect of CBD on workplace drug testing and the impact of Delta-8-THC on marijuana confirmations for Delta 9-THCA.
Dr. David Kuntz, Executive Director for Analytical Toxicology/Laboratory Director Clinical Reference Laboratories
Member price: $50
$60 for non-members
After purchase, you will receive access to a link that allows you to download the video file for this recorded session. The link expires after 60 days.
Related products
Search this site
Stay in touch
Give to NDASA
Invest in safe and drug-free communities and workplaces and support NDASA.
Latest News & Updates
- May 18, 2022A Sad Loss for Our Industry
- Apr 26, 2022NDASA’s Response to Proposed Guidelines for Oral Fluid Testing and Other Changes to 49 CFR Part 40
- Apr 25, 2022Start Your Engines for Conference 2022
- Mar 15, 2022Fast, Clean, Accurate Alcohol Testing – The Future is Here
- Mar 03, 2022Commit to Quality: Lessons Learned From the Search for Reliable COVID Tests
Topics We Track
- Advocacy (2)
- Committee Reports (1)
- DOT (5)
- Drug & Alcohol Testing (17)
- Drug Legislation (8)
- Feature (47)
- FMCSA (3)
- For Drug Testing Industry Professionals (14)
- For Employers and Workplace Safety & Wellness Professionals (12)
- Industry News (8)
- Marijuana & CBD (13)
- Member Benefits (1)
- Membership (2)
- NDASA Conference (8)
- NDASA Guidance (4)
- Opioids (2)
- Resources (21)
- Substance Use (1)
- Substance Use/Addiction (3)
- Training (1)
- Uncategorized (7)
- Workplace Safety (4)